The US Food and Drug Administration (FDA) has approved sarilumab (Kevzara) for the treatment of polyarticular juvenile ...

A 35-year-old man was admitted to the intensive care unit (ICU) with a progressive skin and soft tissue infection of the arm ...

The US Food and Drug Administration (FDA) has granted accelerated approval for Iqirvo (elafibranor; Ipsen) for treatment of ...

The US Food and Drug Administration has approved a supplemental new drug application for tirbanibulin topical ointment, ...

Kratom, used like an opioid, widely available online and elsewhere, and increasingly popular, can cause hyperpigmentation ...

In children with Marfan syndrome who undergo lens removal, the risk for retinal detachment increases 16-fold when capsular ...

MILAN — Seladelpar, an investigational selective peroxisome proliferator-activated receptor delta agonist, achieves both ...

HOUSTON, Texas — Obstructive sleep apnea (OSA) not only affects the patient's health but also disrupts their partner's sleep, ...

BOSTON — Men who stop using performance-enhancing anabolic-androgenic steroids (AAS) experience significant depression, ...

A new report defines the infection-associated chronic condition as lasting at least 3 months, with single or multiple symptoms and without need for confirmatory tests.

The novel method can predict dementia with greater than 80% accuracy and up to 9 years before a diagnosis using resting-state functional magnetic resonance imaging.

Patients with bendopnea are rarely tested for it, yet they appear to be twice as likely to die within 2 years of hospital ...